Last updated on December 2019

Efficacy Safety and Tolerability of AVP-786 for the Treatment of Negative Symptoms of Schizophrenia

Brief description of study

This study will be conducted to evaluate the efficacy, safety, and tolerability of AVP-786, as compared with placebo, for the treatment of negative symptoms of schizophrenia.

Clinical Study Identifier: NCT03896945

Find a site near you

Start Over

Clinical Research Site

Hollywood, FL United States
  Connect »